Lin, H.; Deng, T.; Jiang, L.; Meng, F.; Cao, Y.; Zhang, Y.; Ge, R.; Zhu, X.
Adverse Reactions in Relapsed/Refractory B-Cell Lymphoma Administered with Chimeric Antigen Receptor T Cell Alone or in Combination with Autologous Stem Cell Transplantation. Cancers 2024, 16, 1722.
https://doi.org/10.3390/cancers16091722
AMA Style
Lin H, Deng T, Jiang L, Meng F, Cao Y, Zhang Y, Ge R, Zhu X.
Adverse Reactions in Relapsed/Refractory B-Cell Lymphoma Administered with Chimeric Antigen Receptor T Cell Alone or in Combination with Autologous Stem Cell Transplantation. Cancers. 2024; 16(9):1722.
https://doi.org/10.3390/cancers16091722
Chicago/Turabian Style
Lin, Haolong, Ting Deng, Lijun Jiang, Fankai Meng, Yang Cao, Yicheng Zhang, Renying Ge, and Xiaojian Zhu.
2024. "Adverse Reactions in Relapsed/Refractory B-Cell Lymphoma Administered with Chimeric Antigen Receptor T Cell Alone or in Combination with Autologous Stem Cell Transplantation" Cancers 16, no. 9: 1722.
https://doi.org/10.3390/cancers16091722
APA Style
Lin, H., Deng, T., Jiang, L., Meng, F., Cao, Y., Zhang, Y., Ge, R., & Zhu, X.
(2024). Adverse Reactions in Relapsed/Refractory B-Cell Lymphoma Administered with Chimeric Antigen Receptor T Cell Alone or in Combination with Autologous Stem Cell Transplantation. Cancers, 16(9), 1722.
https://doi.org/10.3390/cancers16091722
